This prompted us to investigate if serum-derived EVs from cancer sera can recapitulate the upregulation of TIMP1 in recipient fibroblasts, promoting the ECM remodelling as a perquisite for the formation of a pre-metastatic niche. The gene discussed is TIMP1; the disease is cancer.